PTJ
MEDP icon

Paul Tudor Jones’s Medpace MEDP Stock Holding History

Paul Tudor Jones’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-900
Closed -$300K – 3321
2024
Q3 		$300K Buy
900
+200
+29% +$76K ﹤0.01% 2322
2024
Q2 		$288K Sell
700
-500
-42% -$198K ﹤0.01% 2021
2024
Q1 		$485K Buy
+1,200
New +$422K ﹤0.01% 1660
2023
Q4 		– Sell
-2,700
Closed -$654K – 2671
2023
Q3 		$654K Buy
+2,700
New +$691K 0.01% 1541
2023
Q1 		– Sell
-3,300
Closed -$701K – 2747
2022
Q4 		$701K Sell
3,300
-300
-8% -$59.9K 0.01% 1354
2022
Q3 		$565K Buy
+3,600
New +$574K 0.01% 1310

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Paul Tudor Jones's MEDP Position: Q2 2026 in Review

Paul Tudor Jones sold out of Medpace (MEDP) in Q2 2026, closing a stake of 8,699 shares — an estimated $4.18M sold.

Paul Tudor Jones first reported a position in MEDP in Q3 2016 and held it in 21 quarters. The position peaked at $50.1M in Q4 2025. 693 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Paul Tudor Jones reported no remaining Medpace position as of Q2 2026 after selling out during the quarter.
  • Paul Tudor Jones sold 8,699 Medpace shares in Q2 2026, an estimated $4.18M.
  • Paul Tudor Jones first reported a position in Medpace in Q3 2016 and held it in 21 quarters.
  • Paul Tudor Jones's Medpace position peaked at $50.1M in Q4 2025.
  • 693 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.